Navigation Links
BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
Date:4/22/2008

FDA agrees to first SPA for an oncolytic product

WOBURN, Mass., April 22 /PRNewswire/ -- BioVex Inc, a biotechnology company developing clinical stage treatments for cancer and the prevention of infectious disease, announced today that the U.S. Food and Drug Administration (FDA) has approved the design of a single, pivotal, Phase III clinical trial evaluating its lead product, OncoVEX(GM-CSF) in previously treated patients with metastatic melanoma. The agreement was made under the Special Protocol Assessment (SPA) procedure.

BioVex is currently concluding a 50-patient Phase II trial for OncoVEX(GM-CSF) as stand alone therapy in patients with unresectable Stage IIIc and Stage IV metastatic melanoma. The trial was designed to measure overall objective response, which is defined as a complete response (CR), where disease is completely eliminated, or partial response (PR), where there is a >30% reduction in disease burden. Interim results from the study demonstrated a highly encouraging rate of durable objective response with multiple patients with metastatic disease at enrollment having been declared disease free following therapy. The full study has been accepted for oral presentation at ASCO on June 1st where the results will be presented.

The Phase III study design agreed with the FDA follows directly from the study design successfully employed in Phase II. The Phase III study will also enroll previously treated patients with unresectable stage IIIc and stage IV disease using OncoVEX(GM-CSF) as monotherapy. The primary efficacy endpoint will also be response rate-based; the primary objective being to demonstrate a statistically significant increase in the rate of objective responses maintained for six months or more, in comparison to control therapy (subcutaneously administered(GM-CSF). The study is intended to enroll 360 evaluable patients randomized such that 240 patients receive OncoVEX(GM-CSF) and 120 patients receive contro
'/>"/>

SOURCE BioVex Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arpida Provides Further Comments on the Pivotal Phase III Trials
2. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
3. PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
4. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
5. DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial
6. Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM)
7. Accumetrics Announces $28.8 Million Financing and Initiation of Pivotal Clinical Trial
8. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
9. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
10. Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
11. First Patient Enrolled in Cogentus Pharmaceuticals Pivotal Phase 3 Trial of Novel Combination Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Texas , Sept. 17, 2014  Lightbeam ... Direct Accountable Care Organization (Physician Direct ACO) to ... their physicians in providing better care while reducing ... Physician Direct Accountable Care Organization ... Network Services (OPNS). The OPNS mission is to ...
(Date:9/17/2014)... , Sept. 17, 2014  Members of the ... Interventional Associates announced today that the enterprise ... enhance its image sharing capabilities and provide immediate ... network failures. In addition, the Dicom Systems enterprise ... disparate PACS systems to more effectively deliver the ...
(Date:9/17/2014)... Calif. , Sept. 17, 2014   ... data analytics solution that brings complete visibility to ... risks in an ever-evolving reimbursement landscape. Powered by ... brings transparency to the critical point between patient ... impact revenue. The solution will improve revenue capture, ...
Breaking Medicine Technology:Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 2Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 3Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 2Dicom Systems' Innovative Software Provides Enhanced Imaging Sharing Capabilities, as Well as Connection Reliability in the Case of Network Failure 3MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3
... GlaxoSmithKline (NYSE: GSK ) confirmed today that a joint ... allow Avandia to remain on the market. Committee members voted for recommendations ... label with additional warnings and restrictions (20) to withdrawal from the U.S. ... , ...
... Services announced today  that the American Board of Radiology (ABR) has qualified ... therapy--as a Practice Quality Improvement (PQI) for the purpose of Maintenance of ... , With ... audit of their beam data through the use of a web portal: ...
Cached Medicine Technology:GlaxoSmithKline Statement in Response to FDA Advisory Committees' Vote on Safety of Avandia® (rosiglitazone) 2GlaxoSmithKline Statement in Response to FDA Advisory Committees' Vote on Safety of Avandia® (rosiglitazone) 3GlaxoSmithKline Statement in Response to FDA Advisory Committees' Vote on Safety of Avandia® (rosiglitazone) 4eDataAudit Receives Approval from the American Board of Radiology 2
(Date:9/17/2014)... sip of a perfectly poured glass of wine leads to ... University, Denmark, have now developed a nanosensor that can mimic ... sensor measures how you experience the sensation of dryness in ... wine, they need to control a number of processes to ... up in the wine bottle. An important part of the ...
(Date:9/17/2014)... U.S. News and World Report ... and three mesothelioma treatment centers made the magazine’s ... law firm Baron and Budd reports. ... Texas MD Anderson Cancer Center and Brigham and ... http://health.usnews.com/best-hospitals/rankings/cancer ) , U.S. News and World Report ...
(Date:9/17/2014)... 17, 2014 Tina Griffin, a Senior Sales ... her chemotherapy but not her fight against cancer. Though weakened ... Florida Suncoast “Race for the Cure” on Saturday, Oct. 11, ... Komen Race for the Cure because I wanted to make ... , As part of her efforts, she is asking those ...
(Date:9/17/2014)... Wailea, Maui, HI (PRWEB) September 17, 2014 ... has announced the eighth annual Wailea Tennis Fantasy ... 19-23, 2014 at Maui’s prestigious Wailea Tennis Club, with ... ranked Lindsay Davenport returning to Wailea, Maui for her ... world-class instruction and match play with Davenport, recently inducted ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 A raucous ... Disease come together to form author Nancy Chovancek’s laughter-filled ... book is a collection of short stories that prove ... on fun. With a positive message of empowerment and ... Chovancek is a proven author with two books under ...
Breaking Medicine News(10 mins):Health News:Nanoscience makes your wine better 2Health News:Nanoscience makes your wine better 3Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 2Health News:Three Mesothelioma Treatment Centers Make U.S. News and World Report’s List of Top Cancer Care Facilities, Baron and Budd Reports 3Health News:Tina Griffin’s Fight Against Cancer Didn’t Stop With her Chemotherapy—Her Next Step Is to Run in the Suncoast ‘Race for the Cure’ Oct. 11 2Health News:Four Seasons Resort Maui at Wailea Announces 8th Annual Wailea Tennis Fantasy Camp 2Health News:Four Seasons Resort Maui at Wailea Announces 8th Annual Wailea Tennis Fantasy Camp 3
... hospitality service portfolio, SHAWNEE, Kan., Dec. 5 ... the healthcare industry, will change its name to ... the new brand is the,expanded service portfolio and ... satisfaction., Avascend currently provides the following core ...
... MISSISSAUGA, ON, Dec. 5 /PRNewswire-FirstCall/ - Cipher Pharmaceuticals,Inc. ... M.D., CFA, has been,appointed to its Board of ... years of experience in the global,healthcare industry. He ... Alpharma, Inc. (NYSE: ALO ), a leading ...
... 5 Wyeth,Pharmaceuticals, a division of Wyeth (NYSE: ... recognized for its leading scientific and pharmaceutical,achievements at ... London,England on December 4. Wyeth received honors for ... are given out by Scrip World Pharmaceutical News,a ...
... bones of their children far more often than moms, and ... than five months old, according to a study in Child ... one study case, a child suffered 31 broken or fractured ... other abusive injuries, including burns, abrasions, bruises or head trauma. ...
... gene involved in communication among brain cells has a direct ... study by scientists supported by the National Institute on Alcohol ... Health (NIH), and the U.S. Army. , Scientists do not ... effect on alcohol consumption, exists in humans. , Known ...
... decrease by 45%, ATLANTA, Dec. 5 ... its ED Patient Flow initiative to,dramatically improve performance. ... a 50% reduction in radiology turnaround time for ... "Various,performance improvement teams working on specific parts of ...
Cached Medicine News:Health News:AVP is Now Avascend 2Health News:Cipher appoints Stefan Aigner to board of directors 2Health News:Cipher appoints Stefan Aigner to board of directors 3Health News:Wyeth Receives Honors at the 2007 Scrip Awards 2Health News:Wyeth Receives Honors at the 2007 Scrip Awards 3Health News:Wyeth Receives Honors at the 2007 Scrip Awards 4Health News:Wyeth Receives Honors at the 2007 Scrip Awards 5Health News:Dads break bones of children more often than moms 2Health News:Scientists identify gene that influences alcohol consumption 2Health News:SciHealth Inc. Helps Mary Washington Hospital Improve Emergency Department Performance 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: